Bioasis Technologies Inc (BIOAF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 02/28
(Values in U.S. thousands)
| 02-2022 | 02-2021 | 02-2020 | 02-2019 | 02-2018 | |
| Sales | 30 | 3,063 | 458 | 1,087 | 459 |
| Cost of Goods | N/A | N/A | N/A | 8 | 364 |
| Gross Profit | 30 | 3,063 | 458 | 1,079 | 95 |
| Operating Expenses | 2,901 | 2,859 | 3,929 | 4,799 | 4,564 |
| Operating Income | -2,871 | 203 | -3,472 | -3,712 | -4,105 |
| Interest Expense | 522 | 0 | 0 | 0 | 0 |
| Other Income | 1,031 | 321 | 411 | 1,058 | -24 |
| Pre-tax Income | -2,363 | 525 | -3,060 | -2,654 | -4,129 |
| Net Income Continuous | -2,363 | 525 | -3,060 | -2,654 | -4,129 |
| Net Income | $-2,363 | $525 | $-3,060 | $-2,654 | $-4,129 |
| EPS Basic Total Ops | -0.03 | 0.01 | -0.05 | -0.05 | -0.08 |
| EPS Basic Continuous Ops | -0.03 | 0.01 | -0.05 | -0.05 | -0.08 |
| EPS Diluted Total Ops | -0.03 | 0.01 | -0.05 | -0.05 | -0.08 |
| EPS Diluted Continuous Ops | -0.03 | 0.01 | -0.05 | -0.05 | -0.08 |
| EPS Diluted Before Non-Recurring Items | -0.03 | 0.01 | -0.05 | -0.05 | -0.08 |
| EBITDA(a) | $-2,828 | $249 | $-3,377 | $-3,657 | $-4,059 |